Ocugen, Inc. — Director's Dealing 2019

Oct 4, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Ocugen, Inc. (OCGN)
CIK: 0001372299
Period of Report: 2019-10-02

Reporting Person: Subramanian Sanjay (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-10-02	Common Stock	P	5000	$1.88	Acquired	5000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-10-01	Stock Options	$2.19	A	23970	Acquired	2029-10-01	Common Stock (23970)	Direct

Footnotes

F1: The option grant has a ten year term and vests in equal installments on the anniversary date over a three year period.